Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Revenue Growth
15.72%
Quarterly · Period ending:
ARMP Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported15.72%period ending
Latest reported15.72%period ending
ARMP Quarterly Revenue YoY % (0.00% → 15.72%)
Year-over-year change
High-resolution chart · PNG
ARMP revenue growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue Growth |
|---|---|
| 15.7215% | |
| 60.6925% | |
| -100% | |
| -100% | |
| -49.1718% | |
| -19.1754% | |
| 142.6939% | |
| -100% | |
| 21.3568% | |
| 45.3853% | |
| -8.4454% | |
| -47.9554% | |
| -35.5987% | |
| 6.269% | |
| 6.9544% | |
| 61.2158% | |
| 15.9475% | |
| 96.2302% | |
| 334.375% | |
| 3,667.7419% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -9.0909% | |
| 31.0345% | |
| -72.8155% | |
| -72.6415% | |
| -82.8125% | |
| -79.7203% | |
| 0.9804% | |
| 3.9216% | |
| 29.2929% | |
| 38.835% | |
| -67.0968% | |
| -1.9231% | |
| 1,337.5% | |
| 3,533.3333% | |
| -1.2739% | |
| 372.7273% | |
| 113.031% | |
| 50.2906% | |
| -19.1277% | |
| -30.4348% | |
| -28.6942% | |
| -25.6316% | |
| 50.4515% | |
| -19.6607% | |
| 21.4215% | |
| 112.7298% | |
| -31.6461% | |
| 106.1728% | |
| 37.0572% | |
| -3.2832% | |
| 21.5% | |
| -38.9255% | |
| -38.526% | |
| -47.0482% | |
| 51.5152% | |
| 130.8194% | |
| -52.2591% | |
| 34.4861% | |
| -76.5916% | |
| -69.679% | |
| 3.7329% | |
| -55.3015% | |
| 5.0093% | |
| -12.5048% | |
| -12.9289% | |
| 5.8539% | |
| 41.1301% | |
| 359.1873% | |
| -12.6912% | |
| 147.5185% | |
| 74.9425% | |
| -59.5714% | |
| 353.0714% | |
| 16.8667% | |
| 67.3077% | |
| -60.5634% | |
| 1,300% | |
| 650% | |
| 333.3333% | |
| 7,000% | |
| -87.5% | |
| -33.3333% | |
| -25% | |
| -93.3333% | |
| 0% | |
| 200% | |
| 100% | |
| 700% | |
| 0% | |
| 100% | |
| -100% | |
| -50% | |
| 0% | |
| 0% | |
| 100% | |
| 0% |